“… 21 The increased binding of bradykinin and bradykinin-2 receptors and the relatively increased bradykinin-1 receptor expression might also cause AE to be more common in some locations. 22 , 23 Taken together, the difference among mediators in their vasoactive potency, sensitivity, and distribution of their receptors, and the characteristics of endothelial tight junctions in different organs may account for AE occurring in different body sites. 24 …”